Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program
Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program
Becomes the second hospital in Austria to utilize Senhance
成爲奧地利第二家使用Senhance的醫院。
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement to lease and utilize a Senhance Surgical System.
美國醫療器械公司Asensus Surgical, Inc.(紐交所美國股票代碼:ASXC)日前宣佈,奧地利LKH-Universitätsklinikum Graz醫院已簽訂租約並將使用Senhance手術系統。
LKH-Universitätsklinikum Graz is a renowned healthcare institution known for its expertise in minimally invasive pediatric and adolescent surgery. This hospital will be the 7th pediatric-focused site to utilize the state-of-the-art Senhance Surgical System using 3mm and 5mm instruments for a variety of minimally invasive procedures.
LKH-Universitätsklinikum Graz是一家知名的醫療機構,以其在小切口小兒和青少年外科方面的專業知識而聞名。該醫院將是第7個使用3mm和5mm工具進行各種微創手術的小兒科專注型站點。
"We are thrilled to collaborate with LKH-Universitätsklinikum Graz for the initiation of our Senhance Surgical System clinical program," said Anthony Fernando, Asensus Surgical President and CEO. "This collaboration demonstrates our commitment to expanding the adoption of our innovative surgical platform to benefit patients and healthcare providers around the world."
Asensus Surgical的總裁兼首席執行官Anthony Fernando表示:"我們很高興與LKH-Universitätsklinikum Graz合作開展Senhance手術系統臨床計劃。這次合作證明了我們擴大我們創新手術平台採用全球患者和醫療保健提供者的承諾。"
"We are excited to partner with Asensus Surgical and incorporate the Senhance Surgical System into our clinical practice," said Professor Holger Till, Head of the Department of Pediatric and Adolescent Surgery at LKH-Universitätsklinikum Graz. "The Senhance System is the first platform to offer 3mm instruments. These small instruments have the potential to enhance surgical outcomes for our young patients, and we look forward to advancing the field of pediatric and adolescent surgery with this cutting-edge platform."
"我們很高興與Asensus Surgical合作,將Senhance手術系統融入我們的臨床實踐中。" LKH-Universitätsklinikum Graz的兒科和青少年外科系主任Holger Till教授說:"Senhance系統是第一個提供3mm工具的平台。這些小工具有可能提高我們年輕患者的外科治療效果,我們期待着使用這個先進的平台推動兒科和青少年外科領域的發展。"
![big](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240717/0-a4012852a70e0b90192f94bf8f7f5e30-0-07c2d06871ca0023718edf569058dbe9.jpg/big)
The Senhance Surgical System is being recognized as an advanced robotic option for pediatric procedures
Senhance手術系統被認爲是兒科手術的先進機器人選擇。
About LKH-Universitätsklinikum Graz
LKH-Universitätsklinikum Graz是坐落在奧地利格拉茨的一家領先的醫療機構,以醫療護理、研究和教育方面的卓越聲譽而聞名。醫院隸屬於格拉茨醫科大學,是該地區卓越的醫療護理、創新和學術卓越中心。LKH-Universitätsklinikum Graz擁有一家綜合性的小兒和青少年外科系,專門提供外科護理服務,治療面廣的患兒,高技術外科手術和先進的技術,提供出色的護理並最大限度地優化患者結果。作爲奧地利的一家領先機構,LKH-Universitätsklinikum Graz致力於通過持續的研究、創新和與全球合作伙伴的合作推進兒科和青少年外科領域的發展。這家醫院致力於爲其患者提供最高水平的護理,同時也是爲下一代醫療保健專業人員提供教育和培訓的中心。同時注重以患者爲中心的護理、創新的技術和跨學科的合作,LKH-Universitätsklinikum Graz努力改善其患者的健康和福祉,爲科學進步做出貢獻,塑造未來的醫療保健。
LKH-Universitätsklinikum Graz is a leading healthcare institution located in Graz, Austria, with a reputation for excellence in medical care, research, and education. The hospital is affiliated with the Medical University of Graz and serves as a prominent center for healthcare delivery, innovation, and academic excellence in the region. LKH-Universitätsklinikum Graz has a comprehensive Department of Pediatric and Adolescent Surgery specializing in providing surgical care for infants, children, and adolescents with a wide range of conditions. The highly skilled and experienced team of surgeons utilizes advanced surgical techniques and state-of-the-art technology to deliver exceptional care and optimize patient outcomes. As a leading institution in Austria, LKH-Universitätsklinikum Graz is committed to advancing the field of pediatric and adolescent surgery through continuous research, innovation, and collaboration with global partners. The hospital is dedicated to providing the highest standard of care to its patients, while also serving as a center for education and training for the next generation of healthcare professionals. With a strong focus on patient-centric care, cutting-edge technology, and interdisciplinary collaboration, LKH-Universitätsklinikum Graz strives to improve the health and well-being of its patients, contribute to scientific advancement, and shape the future of healthcare in Austria and beyond.
Asensus Surgical正在通過世界各地的首個手術室內擴增智能技術革新手術。作爲數字技術領域的屢獲殊榮的領導者,Asensus致力於使手術更易接近和可預測,同時提供始終如一卓越的成果。公司數字化腹腔鏡的新方法已經在全球範圍內安置了系統。Asensus由工程師、醫療專業人員和業界權威領袖領導,由人類智慧驅動和協同驅動。要了解有關Asensus的更多信息,請訪問。
About Asensus Surgical, Inc.
關於Asensus Surgical, Inc.
Asensus Surgical is revolutionizing surgery with the first intra-operative Augmented Intelligence technology approved for use in operating rooms around the world. Recognized as an award-winning leader in digital technology, Asensus is committed to making surgery more accessible and predictable while delivering consistently superior outcomes. The Company's novel approach to digitizing laparoscopy has led to system placements globally. Led by engineers, medical professionals, and industry luminaries, Asensus is powered by human ingenuity and driven by collaboration. To learn more about Asensus, visit .
此新聞稿包括與Senhance手術系統和LKH-Universitätsklinikum Graz啓動Senhance System方案相關的聲明。這些聲明以及其他關於我們未來計劃和目標的聲明,構成了《1933年證券法》第27A節和《1934年證券交易法》第21E節中"前瞻性聲明"的一部分,並打算獲得《1995年私有證券訴訟改革法案》所設立的安全岸免責權利。這樣的聲明受到通常難以預測、超出我們控制範圍的風險和不確定性的影響,並可能導致結果與期望有所不同,包括與LKH-Universitätsklinikum Graz的合作是否證明我們擴大Senhance系統平台的採用以造福全球患者和醫療保健提供者,以及Senhance系統是否將幫助LKH-Universitätsklinikum Graz推進兒科和青少年外科領域的發展。有關公司業務風險和不確定性的討論,請查看我們向證券交易委員會(SEC)提交的備案文件,包括我們於2024年3月22日向SEC提交的截至2023年12月31日的年度報告,和我們向SEC提交的其他備案文件。請注意,這些前瞻性聲明是基於本新聞稿的日期和僅代表本新聞稿的發行日期。我們不承擔公開更新或修訂任何前瞻性聲明的任何義務,無論是因爲有新信息、未來事件或其他原因。
Follow Asensus
關注Asensus
Email Alerts:
電子郵件提醒:
LinkedIn:
領英:
X:
博客
YouTube:
YouTube:
TikTok:
TikTok:
Forward-Looking Statements
前瞻性聲明
This press release includes statements relating to the Senhance Surgical System and LKH-Universitätsklinikum Graz initiating a program with the Senhance System. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the collaboration with LKH-Universitätsklinikum Graz demonstrates our commitment to expanding the adoption of the Senhance System platform to benefit patients and healthcare providers around the world and whether the Senhance System will help LKH-Universitätsklinikum Graz advance the field of pediatric and adolescent surgery. For a discussion of the risks and uncertainties associated with the Company's business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 22, 2024 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
本新聞稿包括有關Senhance手術系統和LKH-Universitätsklinikum Graz啓動計劃的聲明。這些聲明以及其他關於我們未來計劃和目標的聲明,構成了《1933年證券法》第27A節和《1934年證券交易法》第21E節中"前瞻性聲明"的一部分,並打算獲得《1995年私有證券訴訟改革法案》所設立的安全岸免責權利。這樣的聲明受到通常難以預測、超出我們控制範圍的風險和不確定性的影響,並可能導致結果與期望有所不同,包括與LKH-Universitätsklinikum Graz的合作是否證明我們擴大Senhance系統平台的採用以造福全球患者和醫療保健提供者,以及Senhance系統是否將幫助LKH-Universitätsklinikum Graz推進兒科和青少年外科領域的發展。有關公司業務風險和不確定性的討論,請查看我們向證券交易委員會(SEC)提交的備案文件,包括我們於2024年3月22日向SEC提交的截至2023年12月31日的年度報告,和我們向SEC提交的其他備案文件。請注意,這些前瞻性聲明是基於本新聞稿的日期和僅代表本新聞稿的發行日期。我們不承擔公開更新或修訂任何前瞻性聲明的任何義務,無論是因爲有新信息、未來事件或其他原因。
INVESTOR CONTACT:
投資者聯繫方式:
Mark Klausner or Mike Vallie
ICR Westwicke
invest@asensus.com
443-213-0499
Mark Klausner或Mike Vallie
ICR Westwicke
invest@asensus.com
443-213-0499
MEDIA CONTACT:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488
媒體聯繫人:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488
A photo accompanying this announcement is available at
此公告附帶的照片
Senhance Surgical System
Senhance手術系統
![big](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240717/0-a4012852a70e0b90192f94bf8f7f5e30-4-87ea2f53290a52c1209be1356489b7de.jpg/big)
The Senhance Surgical System is being recognized as an advanced robotic option for pediatric procedures
Senhance手術系統被認爲是兒科手術的先進機器人選擇。
Source: Asensus Surgical, Inc.
來源:Asensus Surgical,Inc。
譯文內容由第三人軟體翻譯。